| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
zinc and ring finger 3 | 0.691 | 0.385 | 0.99 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2014 | 2015 | ||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2007 | 2007 | |||||||||
|
dihydropyrimidine dehydrogenase | 0.493 | 0.846 | 3.4E-22 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2007 | 2008 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2002 | 2015 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2009 | 2015 | |||||||||
|
synaptonemal complex protein 1 | 0.670 | 0.577 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
forkhead box P1 | 0.460 | 0.808 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
G antigen 1 | 0.716 | 0.231 | 1.3E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
Kruppel like factor 5 | 0.534 | 0.769 | 0.82 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
RAB, member of RAS oncogene family like 3 | 0.751 | 0.231 | 8.0E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ETAA1 activator of ATR kinase | 0.861 | 0.154 | 7.8E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
nuclear receptor subfamily 4 group A member 1 | 0.490 | 0.731 | 0.37 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
somatostatin receptor 3 | 0.659 | 0.423 | 9.9E-05 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
ATRX chromatin remodeler | 0.452 | 0.808 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
AXL receptor tyrosine kinase | 0.489 | 0.615 | 1.3E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
NFKB inhibitor alpha | 0.487 | 0.885 | 0.99 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
lymphocyte antigen 6 family member E | 0.563 | 0.808 | 0.32 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
BCL2 like 1 | 0.493 | 0.885 | 0.94 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
C-C motif chemokine ligand 20 | 0.474 | 0.846 | 2.4E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
interferon alpha 5 | 0.792 | 0.269 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2004 | |||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2003 | 2003 | |||||||||
|
fibroblast growth factor 13 | 0.514 | 0.808 | 0.89 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
EGF containing fibulin extracellular matrix protein 1 | 0.540 | 0.769 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
annexin A10 | 0.621 | 0.462 | 9.6E-14 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
TNF receptor superfamily member 10b | 0.505 | 0.769 | 2.0E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 |